A detailed history of Jpmorgan Chase & CO transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 427,655 shares of CLBT stock, worth $9.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
427,655
Previous 352,563 21.3%
Holding current value
$9.22 Million
Previous $4.21 Million 70.92%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024

BUY
$11.61 - $17.52 $871,818 - $1.32 Million
75,092 Added 21.3%
427,655 $7.2 Million
Q3 2024

Nov 08, 2024

BUY
$11.61 - $17.52 $871,818 - $1.32 Million
75,092 Added 21.3%
427,655 $7.2 Million
Q2 2024

Dec 26, 2024

SELL
$10.38 - $12.5 $779,454 - $938,650
-75,092 Reduced 17.56%
352,563 $4.21 Million
Q2 2024

Aug 12, 2024

BUY
$10.38 - $12.5 $1.25 Million - $1.51 Million
120,519 Added 51.94%
352,563 $4.21 Million
Q1 2024

Dec 26, 2024

SELL
$8.04 - $12.29 $1.57 Million - $2.4 Million
-195,611 Reduced 45.74%
232,044 $2.57 Million
Q1 2024

May 10, 2024

BUY
$8.04 - $12.29 $292,237 - $446,716
36,348 Added 18.57%
232,044 $2.57 Million
Q4 2023

Dec 26, 2024

SELL
$6.45 - $8.76 $1.5 Million - $2.03 Million
-231,959 Reduced 54.24%
195,696 $1.69 Million
Q4 2023

Feb 12, 2024

BUY
$6.45 - $8.76 $477,022 - $647,863
73,957 Added 60.75%
195,696 $1.69 Million
Q3 2023

Nov 14, 2023

BUY
$6.86 - $8.18 $454,104 - $541,483
66,196 Added 119.18%
121,739 $931,000
Q2 2023

Aug 11, 2023

SELL
$5.3 - $7.2 $150,891 - $204,984
-28,470 Reduced 33.89%
55,543 $399,000
Q1 2023

May 11, 2023

BUY
$4.36 - $6.15 $80,376 - $113,375
18,435 Added 28.11%
84,013 $511,000
Q4 2022

Feb 13, 2023

BUY
$3.99 - $4.95 $36,556 - $45,351
9,162 Added 16.24%
65,578 $286,000
Q3 2022

Nov 14, 2022

SELL
$0.75 - $5.95 $1,857 - $14,732
-2,476 Reduced 4.2%
56,416 $221,000
Q2 2022

Aug 11, 2022

BUY
$4.46 - $7.19 $41,892 - $67,535
9,393 Added 18.98%
58,892 $301,000
Q1 2022

May 11, 2022

BUY
$5.34 - $8.12 $162,389 - $246,929
30,410 Added 159.31%
49,499 $317,000
Q4 2021

Feb 10, 2022

BUY
$7.8 - $11.24 $44,179 - $63,663
5,664 Added 42.19%
19,089 $153,000
Q3 2021

Nov 12, 2021

BUY
$9.26 - $12.15 $124,315 - $163,113
13,425 New
13,425 $124,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $4.09B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.